Longer-term studies would be needed to address whether the fall in TL1A associated with TNF therapy in RA predicts delay in progression of erosions, or development of atherosclerosis, which has also been associated with higher serum levels of TL1A [45]. This evidence concerns the gene TNF and rheumatoid arthritis.